6 news items
Oppenheimer Maintains Outperform on Soleno Therapeutics, Lowers Price Target to $59
SLNO
13 May 24
Oppenheimer analyst Leland Gershell maintains Soleno Therapeutics (NASDAQ:SLNO) with a Outperform and lowers the price target from $65 to $59.
Baird Initiates Coverage On Soleno Therapeutics with Outperform Rating, Announces Price Target of $72
SLNO
10 May 24
Baird analyst Brian Skorney initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and announces Price Target of $72.
Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
SLNO
2 May 24
," "could," "intend," "target," "project," "contemplates," "believes," "estimates," "predicts
Soleno Therapeutics Announces Proposed Public Offering of Common Stock
SLNO
2 May 24
," "target," "project," "contemplates," "believes," "estimates," "predicts," "potential
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
ADXN
ALT
ALTM
29 Apr 24
and maintained a $4 price target.
Cyclacel Pharmaceuticals, Inc
9c9e7ax11fzmttwfv3 t290vhw6pqw253ozwkuy78gtdmw92zh1i017v6
ALB
ALTM
CGEM
29 Apr 24
from Equal-Weight to Overweight and raised its price target from $21 to $45.
Paramount Global
- Prev
- 1
- Next